Hepatobiliary Surgery
Zhou Qi
Chief physician
Overview
Clinical Interests：
Primary liver cancer, Pancreatic cancer, Complex biliary calculi
?
Medical Education：
M.D., Ph.D.
?
Work Experiences：
From July 2004 up to now: As a attending surgeon, a Deputy Chief Physician and a Chief Physician consecutively in the Hepatobiliary Surgery Department, the First Affiliated Hospital of SYSU
?
?
| Visits |
Sunday:
Closed
Monday:
8:00-12:00
939
Tuesday:
Closed
Wednesday:
Closed
Thursday:
Closed
Friday:
Closed
Saturday:
Closed
|
| Address |
Biography
Social service：
The Vice Chairman of Medical Equipment Working Committee of China Medical Education Association
The Director of the Special Committee on Minimally Invasive Hepatobiliary Surgery of Guangdong Health Management Association
The Chief of the Intraoperative Auxiliary Diagnostics Group of Hepatobiliary and Pancreatic Surgery Branch of Guangdong Medical Association;
The Deputy Headmaster of Liver Cancer Group of Guangdong Medical Association;
?
Treatise:
1. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular Carcinoma《AGING》2020
2. Bioinformatics analysis on multiple Gene Expression Omnibus datasets of the hepatitis B virus infection and its response to the interferon-alpha therapy《BMC Infectious Diseases》2020
3. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.《Molecular Carcinogenesis》? 2019
4. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.《Journal of Experimental & Clinical Cancer Research》2019
5. Comprehensive and combined omics analysis reveals factors of ischemia-reperfusion injury in liver transplantation. 《Epigenomics》? 2019
6. Targeting TF-AKT/EGFR Pathway Suppressed the Growth Of Hepatocellular Carcinoma. 《Frontiers in Oncology》? 2019
Monographs:
《Complications of hepatobiliary, pancreatic and splenic surgery》
